KRCA-0008 is a selective ALK/Ack1 inhibitor with IC50s of 12 and 4 nM for ALK and Ack1, respectively. KRCA-0008 can be used for the research of cancer[1][2].
Molecular Weight:
609.12
Purity:
96.72
CAS Number:
[1472795-20-2]
Formula:
C30H37ClN8O4
Target:
Ack1,Anaplastic lymphoma kinase (ALK),Apoptosis
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted